ApoA-IV presented an intriguing finding: its levels were higher in cases, contrary to prior reports of an inverse association with coronary artery disease, primarily attributed to its role in inhibiting vascular inflammation by preventing NF-κB activation [41]. The gene discussed is NFKB1; the disease is coronary artery disorder.